Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MD0T
|
|||
| Drug Name |
Satralizumab
|
|||
| Indication | Neuromyelitis optica spectrum disorder [ICD-11: 8E4A.0] | Approved | [1] | |
| Company |
Chugai Pharma USA Berkeley Heights, NJ RocheBasel, Switzerland
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.